US regulators to weigh controversial peptides backed by RFK Jr

regulate a wide range of biological processes. Some peptide-based medicines, including GLP-1 weight-loss drugs such as Ozempic and Wegovy, have become household names in recent years. But the seven peptides under review this week are a different group of compounds marketed for a broad range of conditions.

They include BPC-157, TB-500 and KPV, which continue reading …